
During the Covid-19 pandemic, several ventures tried to develop vaccines that are not protected by patents and could be fast and easily distributed acround the globe. In the course of the research project “Organizing Creativity under Regulatory Uncertainty: Alternative Approaches to Intellectual Property” (funded by the Austrian Science Fund FWF and the German Research Foundation DFG), we collected data on such alternative, more open approaches to pharmaceutical R&D.
It is with great pleasure that a paper comparing five such cases has now been published in the journal R&D Management. Check out the abstract of the article entitled “Anticipating Knowledge Applicability in Open Science Through Recycling, Mimicking, and Shortcutting” and co-authored with my former PhD student Milena Leybold and long-term collaborators Konstantin Hondros and Sigrid Quack below:
Continue reading “New Article in R&D Management: »Anticipating Knowledge Applicability in Open Science Through Recycling, Mimicking, and Shortcutting«”